Philip Shaul, M.D.
Professor
Endowed Title: Associates First Capital Corporation Distinguished Chair in Pediatrics
Department: Pediatrics
Graduate Programs: Integrative Biology
Professor
Endowed Title: Associates First Capital Corporation Distinguished Chair in Pediatrics
Department: Pediatrics
Graduate Programs: Integrative Biology
General Address
5323 Harry Hines Blvd.
Dallas, TX 75390-9063
Dr. Shaul received his BA from Dartmouth College and his MD from the University of Cincinnati. He received residency training in pediatrics at the Children?s Medical Center of Cincinnati/University of Cincinnati followed by fellowship training in neonatal-perinatal medicine at Women and Infant?s Hospital of Rhode Island/Brown University. He joined the faculty of the University of Texas Southwestern Medical Center at Dallas in 1986, and is currently Professor of Pediatrics and holder of the Lowe Foundation Professorship in Pediatric Critical Care Research at UT Southwestern. He is the Director of the Division of Pulmonary and Vascular Biology in the Department of Pediatrics and a member of the Integrative Biology Graduate Program in the Division of Basic Science. Dr. Shaul was President of the Society for Pediatric Research for 2005-2006.
| Medical School | University of Cincinnati College of Medicine (1981) |
| Residency | Children's Hospital Medical Center -Cincinnati (1984) |
| Fellowship | Brown University/Medical School (1986) |
Featured Publications
FcRIIB mediates C-reactive protein inhibition of endothelial NO synthase
Mineo C, Gormley AK, Yuhanna IS, Osborne-Lawrence S, Gibson LL, Hahner L, Shohet RV, Black S, Salmon JE, Samols D, Karp DR, Thomas GD, Shaul PW Circ. Res. 2005 97 1124-1131
Cholesterol binding, efflux and a PDZ-interacting domain of SR-BI mediate HDL-initiated signaling
Assanasen C, Mineo C, Seetharam D, Yuhanna IS, Marcel YL, Connelly MA, Williams DL, de la Llera-Moya M, Shaul PW, Silver DL J. Clin. Invest. 2005 115 969-977
High density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase
Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, Lu P, Anderson RGW, Mendelshoh ME, Hobbs HH, Shaul PW Nature Med. 2001 7 853-857
Estrogen receptor alpha mediates nongenomic activation of eNOS by estrogen
Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW J. Clin. Invest. 1999 130 401-406
Acylation targets endothelial nitric oxide synthase to plasmalemmal caveolae
Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, Michel T J. Biol. Chem. 1996 271 6518-6522
27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator that inhibits the cardiovascular effects of estrogen
Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Liverman AB, Javitt NB, Shaul PW, Mangelsdorf DJ Nat. Med. 2007
CRP causes downregulation of vascular AT2 receptors and systolic hypertension in mice
Vongpatanasin W, Thomas GD, Schwartz R, Cassis LA, Osborne-Lawrence S, Hahner L, Gibson LL, Black S, Samols D, Shaul PW Circulation 2007 115 1020-1028
Direct interactions with Galpha i and Gbeta-gamma mediate nongenomic signaling by ERalpha
Kumar P, Tall GG, Chambliss KL, Yuhanna IS, Wu Q, Mumby SM, Mineo C, Shaul PW Mol. Endocrinol. 2007 21 1370-1380
CRP downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice
Schwartz R, Osborne-Lawrence S, Hahner L, Gibson LL, Gormley AK, Vongpatanasin W, Zhu W, Word RA, Seetharam D, Black S, Samols D, Mineo C, Shaul PW Circ. Res. 2007 100 1452-1459
High density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I
Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens RL, Marcel YL, Rader DJ, Shaul PW Circ. Res. 2006 98 63-72